Susquehanna International Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $832K | Buy |
25,157
+18,430
| +274% | +$780K | ﹤0.01% | 8382 |
|
|
2025
Q4 | $311K | Buy |
+6,727
| New | +$281K | ﹤0.01% | 9856 |
|
|
2025
Q3 | – | Sell |
-43,339
| Closed | -$1.51M | – | 12606 |
|
|
2025
Q2 | $1.28M | Sell |
43,339
-6,346
| -13% | -$181K | ﹤0.01% | 6809 |
|
|
2025
Q1 | $1.48M | Buy |
49,685
+18,773
| +61% | +$574K | ﹤0.01% | 6242 |
|
|
2024
Q4 | $886K | Buy |
30,912
+23,319
| +307% | +$772K | ﹤0.01% | 7270 |
|
|
2024
Q3 | $293K | Buy |
+7,593
| New | +$271K | ﹤0.01% | 9649 |
|
|
2024
Q2 | – | Sell |
-19,566
| Closed | -$678K | – | 12214 |
|
|
2024
Q1 | $760K | Sell |
19,566
-21,146
| -52% | -$740K | ﹤0.01% | 7524 |
|
|
2023
Q4 | $1.25M | Buy |
40,712
+31,382
| +336% | +$786K | ﹤0.01% | 6432 |
|
|
2023
Q3 | $209K | Sell |
9,330
-3,917
| -30% | -$89.3K | ﹤0.01% | 10140 |
|
|
2023
Q2 | $285K | Sell |
13,247
-12,191
| -48% | -$277K | ﹤0.01% | 9545 |
|
|
2023
Q1 | $610K | Buy |
+25,438
| New | +$675K | ﹤0.01% | 8084 |
|
|
2022
Q4 | – | Sell |
-10,684
| Closed | -$215K | – | 12603 |
|
|
2022
Q3 | $171K | Buy |
+10,684
| New | +$188K | ﹤0.01% | 11065 |
|
|
2022
Q1 | – | Sell |
-17,217
| Closed | -$325K | – | 13134 |
|
|
2021
Q4 | $322K | Buy |
+17,217
| New | +$336K | ﹤0.01% | 10305 |
|
|
2021
Q3 | – | Sell |
-9,734
| Closed | -$210K | – | 12855 |
|
|
2021
Q2 | $230K | Buy |
+9,734
| New | +$225K | ﹤0.01% | 11291 |
|
|
2021
Q1 | – | Sell |
-71,806
| Closed | -$1.71M | – | 12323 |
|
|
2020
Q4 | $1.44M | Buy |
+71,806
| New | +$1.4M | ﹤0.01% | 5833 |
|
|
2020
Q3 | – | Sell |
-29,207
| Closed | -$527K | – | 10640 |
|
|
2020
Q2 | $511K | Sell |
29,207
-804
| -3% | -$15.7K | ﹤0.01% | 7314 |
|
|
2020
Q1 | $490K | Buy |
+30,011
| New | +$619K | ﹤0.01% | 6976 |
|
|
2019
Q4 | – | Sell |
-14,551
| Closed | -$243K | – | 9850 |
|
|
2019
Q3 | $167K | Sell |
14,551
-42,629
| -75% | -$487K | ﹤0.01% | 9246 |
|
|
2019
Q2 | $752K | Buy |
+57,180
| New | +$765K | ﹤0.01% | 6336 |
|
|
2018
Q3 | – | Sell |
-78,259
| Closed | -$1.39M | – | 9446 |
|
|
2018
Q2 | $1.87M | Buy |
78,259
+19,741
| +34% | +$485K | 0.01% | 4130 |
|
|
2018
Q1 | $1.5M | Sell |
58,518
-8,359
| -12% | -$199K | 0.01% | 4455 |
|
|
2017
Q4 | $1.24M | Buy |
66,877
+41,414
| +163% | +$593K | ﹤0.01% | 4823 |
|
|
2017
Q3 | $267K | Buy |
+25,463
| New | +$281K | ﹤0.01% | 7581 |
|
|
2017
Q1 | – | Sell |
-23,830
| Closed | -$354K | – | 9092 |
|
|
2016
Q4 | $371K | Buy |
+23,830
| New | +$396K | ﹤0.01% | 7563 |
|
|
2015
Q4 | – | Sell |
-9,087
| Closed | -$201K | – | 9492 |
|
|
2015
Q3 | $201K | Buy |
+9,087
| New | +$164K | ﹤0.01% | 8693 |
|
Other funds holding COLL
EAM
VCM
